Nuclear Medicine and Molecular Imaging, published by SPRINGER HEIDELBERG, stands as a pivotal platform in the interdisciplinary field of radiology and nuclear medicine, focusing on innovative research and developments from 2010 to 2024. With its ISSN 1869-3474 and E-ISSN 1869-3482, this journal aims to disseminate advanced studies that explore the diagnostic and therapeutic applications of nuclear medicine technologies. Operating from Germany, it has positioned itself in the Q3 category within the Radiology, Nuclear Medicine and Imaging sector, showcasing its relevance among peer journals, with a Scopus rank of #204 out of 333. This journal not only serves as an essential resource for researchers and practitioners eager to stay abreast of modern methodologies and findings but also underscores the crucial advancements in molecular imaging techniques. Although currently not an open-access journal, it doesn't detract from its mission to promote knowledge exchange among academia and the medical community, thus paving the way for innovative solutions and improved patient care in nuclear medicine.

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

Current Radiopharmaceuticals, published by Bentham Science Publishers Ltd, is an esteemed journal dedicated to advancing the field of radiopharmaceuticals. With an ISSN of 1874-4710 and an E-ISSN of 1874-4729, this journal has been a significant platform for researchers since its inception in 2009, and will continue to contribute to the literature until at least 2024. Current Radiopharmaceuticals is recognized for its impactful contributions, holding a record of Q3 in Pharmacology and Q2 in Radiology, Nuclear Medicine, and Imaging as of 2023, illustrating its vital role in these domains. The journal aims to provide a comprehensive overview of the latest techniques, applications, and innovations within the field of radiopharmaceutical science, catering to a diverse audience of researchers, professionals, and students. Despite its significant contributions, the journal remains committed to enriching the academic community with high-quality, peer-reviewed articles that can be accessed worldwide, reflecting a dedication to open dialogue and knowledge dissemination in radiopharmaceutical research.

World Journal of Nuclear Medicine, published by THIEME MEDICAL PUBL INC, is a premier peer-reviewed journal dedicated to advancing the field of nuclear medicine. With an Open Access model established since 2011, this journal ensures that high-quality research is accessible to a wide audience, fostering knowledge sharing and collaboration among researchers, clinicians, and students alike. The journal aims to publish innovative studies, reviews, and clinical trials that contribute significantly to both the theoretical and practical aspects of nuclear medicine, enhancing diagnostic and therapeutic techniques within this critical area of healthcare. As the journal continues to grow in visibility and impact, it remains an essential resource for those seeking to stay at the forefront of advancements in nuclear medicine.

EJNMMI Physics, the premier journal for advancements in nuclear medicine and imaging, is published by Springer in Switzerland and has been an open-access outlet since 2014, allowing for broad dissemination of critical research findings. With an ISSN of 2197-7364, the journal aims to bridge the gap between state-of-the-art physics and practical applications in biomedical engineering and radiology. Its impressive Q1 ranking in multiple categories, including Biomedical Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging, exemplifies its significant impact in the field. The journal boasts exceptional metrics with Scopus rankings placing it in the top echelons across disciplines, including a 6th position out of 58 in Radiation, and serves as an essential resource for researchers, professionals, and students who are eager to contribute to and stay informed about cutting-edge scientific advancements. With a broadening scope until 2024, EJNMMI Physics is an indispensable tool for those dedicated to pushing the boundaries of knowledge in medical physics and imaging technologies.

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

European Journal of Hybrid Imaging, published by SpringerNature, stands as a pivotal platform for scholarly discourse in the rapidly evolving fields of hybrid imaging technologies and methodologies. Since its inception in 2017, this open access journal has significantly contributed to the interdisciplinary interface of biophysics, computer science, molecular medicine, and radiology. With its current standing in the Q2 and Q3 quartiles across various categories, it provides valuable insights and research outputs pertinent to both academic and clinical practitioners. The journal's rigorous peer-review process ensures the highest standards of scholarly integrity, while its open access format promotes global accessibility and encourages collaborative research efforts. Covering a diverse range of topics pertinent to hybrid imaging, the journal serves as an essential resource for researchers, professionals, and students alike, fostering innovation and knowledge exchange within the scientific community.